Page 13 - Technology Development Group News Today

The condition, CD3 delta SCID, is caused by a mutation that prevents the production of the CD3 delta protein that is needed for the normal development of T cells

On February 22, 2023, the European Patent Office published a patent application from Apple titled "Multi-Device Continuity for use with Extended Reality (XR) Systems." It describes how a user with an iDevice (iPhone/iPad) or Mac (desktop of laptop) could transfer a document in-progress to an XR Headset display to allow a user to edit or finish said document in Extended Reality.

Everyone in the Apple community knows that Apple is famous for keeping its future products under wraps, but even by those standards the company’s Exploratory Design Group is the most secretive of all. A new report shines a light on this secretive group ...

A profile into Apple's Exploratory Design Group explains how teams work in secret on next-generation technologies, including the often-rumored non-invasive glucose monitor for the Apple Watch.

Apple has a moonshot-style project underway that dates back to the Steve Jobs era: noninvasive and continuous blood glucose monitoring.

A profile into Apples Exploratory Design Group explains how teams work in secret on next-generation technologies, including the often-rumored non-invasive glucose monitor for the Apple Watch.

This week the US Patent & Trademark Office published a patent application from Apple that relates to the next-generation of Avatar/Memoji customization that will allow a users to enroll their own custom glasses, hat or other accessory to be integrated into their Memoji through a machine learning process.

The goal of this secret endeavor — dubbed E5 — is to measure how much glucose is in someone’s body without needing to prick the skin for blood

Apple Inc. has a moonshot-style project underway that dates back to the Steve Jobs era: noninvasive and continuous blood glucose monitoring.

Apple Inc has a moonshot-style project underway that dates back to the Steve Jobs era: noninvasive and continuous blood glucose monitoring.